MASSIRONI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 3.415
AS - Asia 3.323
EU - Europa 1.932
SA - Sud America 421
AF - Africa 81
OC - Oceania 5
Totale 9.177
Nazione #
US - Stati Uniti d'America 3.236
SG - Singapore 1.028
VN - Vietnam 814
IT - Italia 595
CN - Cina 543
HK - Hong Kong 456
RU - Federazione Russa 360
BR - Brasile 313
DE - Germania 240
IE - Irlanda 182
SE - Svezia 170
CA - Canada 130
FR - Francia 89
IN - India 76
BD - Bangladesh 75
GB - Regno Unito 70
KR - Corea 59
ID - Indonesia 48
AR - Argentina 40
FI - Finlandia 37
MX - Messico 34
NL - Olanda 31
SA - Arabia Saudita 29
UA - Ucraina 28
ES - Italia 27
PL - Polonia 27
ZA - Sudafrica 27
IQ - Iraq 25
JP - Giappone 25
PH - Filippine 23
AT - Austria 22
TR - Turchia 22
CH - Svizzera 21
PK - Pakistan 21
PE - Perù 14
VE - Venezuela 14
EC - Ecuador 13
KE - Kenya 13
CO - Colombia 11
MY - Malesia 11
MA - Marocco 10
UZ - Uzbekistan 10
EG - Egitto 9
BE - Belgio 8
JO - Giordania 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
TW - Taiwan 6
MM - Myanmar 5
TH - Thailandia 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
LT - Lituania 4
SN - Senegal 4
LB - Libano 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
NP - Nepal 2
SR - Suriname 2
TJ - Tagikistan 2
AM - Armenia 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MQ - Martinica 1
NC - Nuova Caledonia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.177
Città #
Singapore 714
Ann Arbor 510
Hong Kong 446
Ashburn 353
San Jose 326
Ho Chi Minh City 256
Hanoi 185
Dublin 177
Milan 160
Frankfurt am Main 155
Los Angeles 131
Chandler 118
Hefei 117
New York 101
Toronto 96
Chicago 94
Dallas 81
Santa Clara 80
Beijing 77
Fairfield 67
Wilmington 65
Council Bluffs 60
The Dalles 60
Shanghai 55
Seoul 50
Buffalo 49
Houston 45
Moscow 42
Princeton 41
Rome 41
Lauterbourg 38
Haiphong 36
Boardman 34
Jakarta 34
Da Nang 32
São Paulo 32
Woodbridge 32
London 28
Seattle 26
Helsinki 25
Munich 23
Cambridge 22
Florence 21
Orem 21
Lawrence 20
Warsaw 20
Ha Long 19
Tokyo 19
Altamura 17
Guangzhou 17
Montreal 17
Nuremberg 17
Rio de Janeiro 17
San Diego 17
Zurich 17
Bari 16
Biên Hòa 16
Denver 16
Hải Dương 16
Ninh Bình 16
Chennai 15
Naples 15
Bắc Ninh 14
Dhaka 14
Hangzhou 14
Phoenix 14
Thái Nguyên 13
Stockholm 12
Brooklyn 11
Lima 11
Mexico City 11
Salt Lake City 11
Atlanta 10
Johannesburg 10
Tashkent 10
Vũng Tàu 10
Bình Dương 9
Bắc Giang 9
Davao City 9
Guayaquil 9
Mumbai 9
Nairobi 9
Bologna 8
Brasília 8
Can Tho 8
Columbus 8
Jeddah 8
Miami 8
Newark 8
Phủ Lý 8
Quận Một 8
Roccalumera 8
Vienna 8
Amman 7
Belo Horizonte 7
Boston 7
Cairo 7
Desio 7
Garbagnate Milanese 7
Kuala Lumpur 7
Totale 5.819
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 729
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 344
Understanding short bowel syndrome: Current status and future perspectives 321
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 318
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 309
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 302
High rates of 30-day mortality in patients with cirrhosis and COVID-19 301
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 287
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 281
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 281
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 278
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 271
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 243
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 240
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 228
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 224
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 222
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 220
Eosinophilic esophagitis: does age matter? 219
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 218
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 214
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 202
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 189
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 188
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 182
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 180
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 176
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 175
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 174
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 172
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 169
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 151
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 148
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 141
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 137
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 137
Systematic review-Pancreatic involvement in inflammatory bowel disease 136
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 129
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 126
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 126
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 116
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 116
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 38
Totale 9.358
Categoria #
all - tutte 31.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022411 38 43 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.891 90 164 157 77 148 99 137 57 152 334 207 269
2025/20265.086 979 397 318 556 549 246 684 187 333 333 247 257
Totale 9.358